These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31128216)

  • 1. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
    Fagan RJ; Dingwall AK
    Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer COMPASS: navigating the functions of MLL complexes in cancer.
    Ford DJ; Dingwall AK
    Cancer Genet; 2015 May; 208(5):178-91. PubMed ID: 25794446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.
    Rao RC; Dou Y
    Nat Rev Cancer; 2015 Jun; 15(6):334-46. PubMed ID: 25998713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.
    Wang LH; Aberin MAE; Wu S; Wang SP
    Biochem Soc Trans; 2021 Jun; 49(3):1041-1054. PubMed ID: 34156443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical perspectives on targeting KMT2 methyltransferases in cancer.
    Zhai X; Brownell JE
    Trends Pharmacol Sci; 2021 Aug; 42(8):688-699. PubMed ID: 34074527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT2C and KMT2D aberrations in breast cancer.
    Tinsley E; Bredin P; Toomey S; Hennessy BT; Furney SJ
    Trends Cancer; 2024 Jun; 10(6):519-530. PubMed ID: 38453563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Activity of Histone-Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis.
    Poreba E; Lesniewicz K; Durzynska J
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3.
    Seehawer M; Li Z; Nishida J; Foidart P; Reiter AH; Rojas-Jimenez E; Goyette MA; Yan P; Raval S; Munoz Gomez M; Cejas P; Long HW; Papanastasiou M; Polyak K
    Nat Cell Biol; 2024 Jul; 26(7):1165-1175. PubMed ID: 38926506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
    Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
    Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.
    Ansari KI; Mishra BP; Mandal SS
    Biochim Biophys Acta; 2008 Jan; 1779(1):66-73. PubMed ID: 18082152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
    Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
    Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
    Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KMT2 Family of H3K4 Methyltransferases: Enzymatic Activity-dependent and -independent Functions.
    Van HT; Xie G; Dong P; Liu Z; Ge K
    J Mol Biol; 2024 Apr; 436(7):168453. PubMed ID: 38266981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.
    Hu D; Gao X; Cao K; Morgan MA; Mas G; Smith ER; Volk AG; Bartom ET; Crispino JD; Di Croce L; Shilatifard A
    Mol Cell; 2017 Feb; 65(3):460-475.e6. PubMed ID: 28157506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
    Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
    J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone recognition and nuclear receptor co-activator functions of Drosophila cara mitad, a homolog of the N-terminal portion of mammalian MLL2 and MLL3.
    Chauhan C; Zraly CB; Parilla M; Diaz MO; Dingwall AK
    Development; 2012 Jun; 139(11):1997-2008. PubMed ID: 22569554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.
    Nayak A; Viale-Bouroncle S; Morsczeck C; Muller S
    Mol Cell; 2014 Jul; 55(1):47-58. PubMed ID: 24930734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2C/D COMPASS complex-associated diseases [K
    Lavery WJ; Barski A; Wiley S; Schorry EK; Lindsley AW
    Clin Epigenetics; 2020 Jan; 12(1):10. PubMed ID: 31924266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.
    Kubo N; Chen PB; Hu R; Ye Z; Sasaki H; Ren B
    Mol Cell; 2024 May; 84(9):1742-1752.e5. PubMed ID: 38513661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.